The present invention is an addition reaction type polyorganosiloxane composition which can be cured rapidly at room temperature. A cured product of the composition exhibits high elongation, excellent stress relaxation properties and good reliability under conditions of high temperature and high humidity and exhibits excellent reliability in cold/heat cycling. The composition contains: (A1) a straight chain polysiloxane containing alkenyl groups at both terminals; (B1) a straight chain polysiloxane containing SiH groups at both terminals; (B2) a crosslinkable polyorganohydrogensiloxane; one or more types selected from the group consisting of (A2) a straight chain polysiloxane containing an alkenyl group at one terminal and (B3) a straight chain polysiloxane containing a SiH group at one terminal; and (C) a platinum-based catalyst. The content of component A2 is 0-60 parts by weight relative to a total of 100 parts by weight of components A1 and A2, and the value of (HB1+HB2+HB3)/(ViA1+ViA2) (in the formula, ViA1, ViA2, HB1, HB2 and HB3 are as disclosed in the description) is 0.6-2.2.
|
15. A curable polyorganosiloxane composition comprising:
(A1) an alkenyl group-containing polyorganosiloxane represented by the following formula (I):
##STR00019##
wherein:
each ra1 is independently a C2-C6 alkenyl group,
each rb1 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and n1 is a value such that the viscosity of the component (A1) at 23° C. is 10 to 1,000,000 mPa·s;
(B1) a polyorganohydrogensiloxane represented by the following formula (II):
##STR00020##
wherein:
each rc1 is a hydrogen atom,
each rb2 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n2 is a value such that the viscosity of the component (B1) at 23° C. is 0.1 to 300 mPa·s;
(B2) a polyorganohydrogensiloxane comprising a rb32rc2SiO1/2 unit (wherein each rb3 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and rc2 is a hydrogen atom) and a SiO4/2 unit, and having three or more hydrogen atoms bonded to silicon atoms per molecule;
at least one member selected from the group consisting of (A2) an alkenyl group-containing polyorganosiloxane represented by the following formula (III):
##STR00021##
wherein:
each ra2 is independently a C2-C6 alkenyl group,
each rb4 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n3 is a value such that the viscosity of the component (A2) at 23° C. is 10 to 1,000,000 mPa·s,
and
(B3) a linear polyorganohydrogensiloxane represented by the following formula (IV):
##STR00022##
wherein:
rb3 is a hydrogen atom,
each rb5 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n4 is a value such that the viscosity of the component (B3) at 23° C. is 0.1 to 300 mPa·s; and
(C) a platinum-based catalyst,
wherein the amount of the component (A2) is 0 to 60 parts by weight, relative to 100 parts by weight of the total of the components (A1) and (A2), and the value of (HB1+HB2+HB3)/(ViA1+ViA2) is 0.6 to 2.2, wherein Vim is the molar number of the alkenyl groups of the component (A1), ViA2 is the molar number of the alkenyl groups of the component (A2), HB1 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B1), HB2 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B2), and HB3 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B3), and
wherein the curable polyorganosiloxane composition contains the component (B3), wherein the value of (HB1+HB2+HB3)/ViA1 is 0.6 to 2.5.
1. A curable polyorganosiloxane composition comprising:
(A1) an alkenyl group-containing polyorganosiloxane represented by the following formula (I):
##STR00011##
wherein:
each ra1 is independently a C2-C6 alkenyl group,
each rb1 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n1 is a value such that the viscosity of the component (A1) at 23° C. is 10 to 1,000,000 m·Pas;
(B1) a polyorganohydrogensiloxane represented by the following formula (II):
##STR00012##
wherein:
each rc1 is a hydrogen atom,
each rb2 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n2 is a value such that the viscosity of the component (B1) at 23° C. is 0.1 to 300 m·Pas;
(B2) a polyorganohydrogensiloxane comprising a rb32rc2SiO1/2 unit (wherein each rb3 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and rc2 is a hydrogen atom) and a SiO4/2 unit, and having three or more hydrogen atoms bonded to silicon atoms per molecule;
at least one member selected from the group consisting of (A2) an alkenyl group-containing polyorganosiloxane represented by the following formula (III):
##STR00013##
wherein:
each ra2 is independently a C2-C6 alkenyl group,
each rb4 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n3 is a value such that the viscosity of the component (A2) at 23° C. is 10 to 1,000,000 mPa·s,
and
(B3) a linear polyorganohydrogensiloxane represented by the following formula (IV):
##STR00014##
wherein:
rc3 is a hydrogen atom,
each rb5 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n4 is a value such that the viscosity of the component (B3) at 23° C. is 0.1 to 300 mPa·s; and
(C) a platinum-based catalyst,
wherein the amount of the component (A2) is 0 to 60 parts by weight, relative to 100 parts by weight of the total of the components (A1) and (A2), and the value of (HB1+HB2+HB3)/(ViA1+ViA2) is 0.6 to 2.2, wherein Vim is the molar number of the alkenyl groups of the component (A1), ViA2 is the molar number of the alkenyl groups of the component (A2), HB1 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B1), HB2 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B2), and HB3 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B3), and
wherein the component (B2) is a cyclic polyorganohydrogensiloxane having a cyclic siloxane skeleton formed from 3 to 5 SiO4/2 units, in which two rb32rc2SiO1/2 units are bonded to each SiO4/2 unit.
10. A curable polyorganosiloxane composition comprising:
(A1) an alkenyl group-containing polyorganosiloxane represented by the following formula (I):
##STR00015##
wherein:
each ra1 is independently a C2-C6 alkenyl group,
each rb1 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n1 is a value such that the viscosity of the component (A1) at 23° C. is 10 to 1,000,000 mPa·s;
(B1) a polyorganohydrogensiloxane represented by the following formula (II):
##STR00016##
wherein:
each rc1 is a hydrogen atom,
each rb2 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n2 is a value such that the viscosity of the component (B1) at 23° C. is 0.1 to 300 mPa·s;
(B2) a polyorganohydrogensiloxane comprising a rb32rc2SiO1/2 unit (wherein each rb3 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and rc2 is a hydrogen atom) and a SiO4/2 unit, and having three or more hydrogen atoms bonded to silicon atoms per molecule;
at least one member selected from the group consisting of (A2) an alkenyl group-containing polyorganosiloxane represented by the following formula (III):
##STR00017##
wherein:
each ra2 is independently a C2-C6 alkenyl group,
each rb4 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n3 is a value such that the viscosity of the component (A2) at 23° C. is 10 to 1,000,000 mPa·s,
and
(B3) a linear polyorganohydrogensiloxane represented by the following formula (IV):
##STR00018##
wherein:
rb3 is a hydrogen atom,
each rb5 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and n4 is a value such that the viscosity of the component (B3) at 23° C. is 0.1 to 300 mPa·s;
and
(C) a platinum-based catalyst,
wherein the amount of the component (A2) is 0 to 60 parts by weight, relative to 100 parts by weight of the total of the components (A1) and (A2), and the value of (HB1+HB2+HB3)/(ViA1+ViA2) is 0.6 to 2.2, wherein Vim is the molar number of the alkenyl groups of the component (A1), ViA2 is the molar number of the alkenyl groups of the component (A2), HB1 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B1), HB2 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B2), and HB3 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B3),
wherein the curable polyorganosiloxane composition contains the component (A2), wherein the value of (HB1+HB2)/(ViA1+ViA2) is 0.6 to 2.2, and
wherein the amount of the component (A2) is 5 to 37 parts by weight, relative to 100 parts by weight of the total of the components (A1) and (A2), the value of (HB1+HB2)/(ViA1+ViA2) is 0.6 to 0.99, and the value of HB1/(HB1+HB2) is 0.3 to 0.8.
2. The curable polyorganosiloxane composition according to
3. The curable polyorganosiloxane composition according to
4. The curable polyorganosiloxane composition according to
5. The curable polyorganosiloxane composition according to
6. The curable polyorganosiloxane composition according to
7. The curable polyorganosiloxane composition according to
8. The curable polyorganosiloxane composition according to
9. An image display device which has a base portion having an image display part for the image display device and a light-transmitting protective portion, wherein the base portion is adhered to the protective portion using the curable polyorganosiloxane composition according to
11. The curable polyorganosiloxane composition according to
12. An image display device which has a base portion having an image display part for the image display device and a light-transmitting protective portion, wherein the base portion is adhered to the protective portion using the curable polyorganosiloxane composition according to
13. The curable polyorganosiloxane composition according to
14. The curable polyorganosiloxane composition according to
16. The curable polyorganosiloxane composition according to
17. The curable polyorganosiloxane composition according to
18. The curable polyorganosiloxane composition according to
19. An image display device which has a base portion having an image display part for the image display device and a light-transmitting protective portion, wherein the base portion is adhered to the protective portion using the curable polyorganosiloxane composition according to
|
The present invention relates to a curable polyorganosiloxane composition, and particularly relates to a curable polyorganosiloxane composition for use in adhering a base portion having an image display part for an image display device to a light-transmitting protective portion.
An image display device such as a cathode ray tube, liquid crystal, plasma or organic EL image display device, is generally composed of, as a polarization splitting element, a polarization split-type diffraction optical element (a holographic color filter), which diffracts and disperse an incident beam and selectively condenses the resultant lights in the separate wavelength regions on the positions corresponding to the respective picture elements of R (red), G (green) and B (blue) colors formed on a polarization modulation element. Especially, an image display device of a panel type generally has a pair of substrates, at least one of which is a substrate having light transmission properties, such as glass, and has a display area (an image display part) disposed between the substrates, wherein in the display area a number of picture elements composed of a semiconductor layer, a fluorescent layer or a light emitting layer constituting an active element are arranged in a matrix form. In the image display device of a panel type, a gap between the display area (the image display part) and a protective portion formed from glass or an optical plastic such as an acrylic resin, is airtightly sealed using an adhesive.
As the adhesive used in the above-mentioned sealing, an ultraviolet curing resin composition using an acrylic resin is not used but a thermosetting resin composition is generally used, due to the structure of the image display device, for example, in which a light blocking paint is applied to the outer frame portion of the protective portion.
With respect to electronic parts such as a transistor, a diode, a capacitor, a coil, an LSI and an IC, which are sealed using a sealing resin, such as an epoxy resin or a polyphenylene sulfide resin, Patent Literature 1 discloses a technique in which a gap frequently occurred at the interface between the sealing resin and a lead of the electronic part, or a gap inevitably present in the electronic part due to its structure is impregnated with a specific thermosetting silicone resin composition in a liquid state and the resin composition is thermally cured to recover the sealed state.
Patent Literature 1: Japanese Patent Application Kokai Publication No. H9-169908
The thermosetting silicone resin composition disclosed in Patent Literature 1 uses a chained polyorganohydrogensiloxane which has three or more hydrogen atoms bonded to silicon atoms per molecule in a side chain of the molecular chain. However, the thermosetting silicone resin composition disclosed in Patent Literature 1 has low reactivity, and therefore has problems that the composition is cured slowly at low temperatures and that the composition is not cured in a predetermined time.
In addition, an adhesive using the silicone resin composition poses a problem that, after substrates are laminated each other, air bubbles are likely to be generated in the adhesive under high-temperature and high-humidity conditions, causing the visibility to be poor. Further, when a cured product of the silicone resin composition has poor flexibility, a cured product of the composition used for laminating a PMMA (polymethyl methacrylate) panel and an LCD (a liquid crystal display) panel, which are members used in an image display device, cannot relax a stress caused due to warpage of PMMA. Therefore, the silicone resin composition has problems that a crack is generated in the cured product of the composition and the cured product of the composition is peeled from the panel.
An object of the present invention is to provide an addition reaction-type polyorganosiloxane composition having a fast-curing property at room temperature, wherein a cured product of the composition has high elongation, excellent stress relaxation, good reliability properties under high-temperature and high-humidity conditions, and excellent cold heat cycle reliability.
The present invention has the following constitutions.
[1] A curable polyorganosiloxane composition comprising:
(A1) an alkenyl group-containing polyorganosiloxane represented by the following formula (I):
##STR00001##
wherein:
each Ra1 is independently a C2-C6 alkenyl group,
each Rb1 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n1 is a value such that the viscosity of the component (A1) at 23° C. is 10 to 1,000,000 mPa·s;
(B1) a polyorganohydrogensiloxane represented by the following formula (II):
##STR00002##
wherein:
each Rc1 is a hydrogen atom,
each Rb2 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n2 is a value such that the viscosity of the component (B1) at 23° C. is 0.1 to 300 mPa·s;
(B2) a polyorganohydrogensiloxane comprising a Rb32Rc2SiO1/2 unit (wherein each Rb3 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and Rc2 is a hydrogen atom) and a SiO4/2 unit, and having three or more hydrogen atoms bonded to silicon atoms per molecule;
at least one member selected from the group consisting of (A2) an alkenyl group-containing polyorganosiloxane represented by the following formula (III):
##STR00003##
wherein:
each Ra2 is independently a C2-C6 alkenyl group,
each Rb4 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n3 is a value such that the viscosity of the component (A2) at 23° C. is 10 to 1,000,000 mPa·s,
and
(B3) a linear polyorganohydrogensiloxane represented by the following formula (IV):
##STR00004##
wherein:
Rc3 is a hydrogen atom,
each Rb5 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n4 is a value such that the viscosity of the component (B3) at 23° C. is 0.1 to 300 mPa·s; and
(C) a platinum-based catalyst,
wherein the amount of the component (A2) is 0 to 60 parts by weight, relative to 100 parts by weight of the total of the components (A1) and (A2), and the value of (HB1+HB2+HB3)/(ViA1+ViA2) is 0.6 to 2.2, wherein ViA1 is the molar number of the alkenyl groups of the component (A1), ViA2 is the molar number of the alkenyl groups of the component (A2), HB1 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B1), HB2 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B2), and HB3 is the molar number of the hydrogen atoms bonded to the silicon atoms of the component (B3).
[2] The curable polyorganosiloxane composition according to item [1], wherein the component (B2) is a cyclic polyorganohydrogensiloxane having a cyclic siloxane skeleton formed from 3 to 5 SiO4/2 units, in which two Rb32Rc2SiO1/2 units are bonded to each SiO4/2 unit.
[3] The curable polyorganosiloxane composition according to item [1] or [2], which contains the component (A2), wherein the value of (HB1+HB2)/(ViA1+ViA2) is 0.6 to 2.2.
[4] The curable polyorganosiloxane composition according to item [3], wherein the amount of the component (A2) is 5 to 37 parts by weight, relative to 100 parts by weight of the total of the components (A1) and (A2), the value of (HB1+HB2)/(ViA1+ViA2) is 0.6 to 0.99, and the value of HB1/(HB1+HB2) is 0.3 to 0.8.
[5] The curable polyorganosiloxane composition according to any one of items [1] to [4], which contains the component (B3), wherein the value of (HB1+HB2+HB3)/ViA1 is 0.6 to 2.5.
[6] The curable polyorganosiloxane composition according to item [5], wherein the value of (HB1+HB2+HB3)/ViA1 is 0.6 to 0.99.
[7] The curable polyorganosiloxane composition according to any one of items [1] to [6], which is for adhering a base portion having an image display part for an image display device to a light-transmitting protective portion.
[8] An image display device which has a base portion having an image display part for the image display device and a light-transmitting protective portion, wherein the base portion is adhered to the protective portion using the curable polyorganosiloxane composition according to any one of items [1] to [7].
In the present invention, there is provided an addition reaction-type polyorganosiloxane composition having a fast-curing property at room temperature, wherein a cured product of the composition has high elongation, excellent stress relaxation, good reliability properties under high-temperature and high-humidity conditions, and excellent cold heat cycle reliability.
[Curable Polyorganosiloxane Composition]
The curable polyorganosiloxane composition (hereinafter, frequently referred to simply as “the composition”) comprises (A1); (B1); (B2); at least one member selected from the group consisting of (A2) and (B3); and (C) a platinum-based catalyst, wherein the amount of (A2) is 0 to 60 parts by weight, relative to 100 parts by weight of the total of (A1) and (A2), and the value of (HB1+HB2+HB3)/(ViA1+ViA2) is 0.6 to 2.2, wherein ViA1 is the molar number of the alkenyl groups of (A1), ViA2 is the molar number of the alkenyl groups of (A2), HB1 is the molar number of the hydrogen atoms bonded to the silicon atoms of (B1), HB2 is the molar number of the hydrogen atoms bonded to the silicon atoms of (B2), and HB3 is the molar number of the hydrogen atoms bonded to the silicon atoms of (B3).
The composition contains “a combination of (A2) and (B3)”, “(A2)” or “(B3)”. When the composition contains (A2) and does not contain (B3), the “(HB1+HB2+HB3)/(ViA1+ViA2)” is “(HB1+HB2)/(ViA1+ViA2)”. When the composition contains (B3) and does not contain (A2), the “(HB1+HB2+HB3)/(ViA1+ViA2)” is “(HB1+HB2+HB3)/ViA1”, and the amount of (A2) contained is 0 part by weight, relative to 100 parts by weight of the total of (A1) and (A2).
(B2) is also referred to as “a crosslinkable polyorganohydrogensiloxane”.
(1) (A1) Alkenyl group-containing polyorganosiloxane represented by the formula (I)
(A1) is represented by the following formula (I):
##STR00005##
wherein:
each Ra1 is independently a C2-C6 alkenyl group,
each Rb1 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n1 is a value such that the viscosity of the component (A1) at 23° C. is 10 to 1,000,000 mPa·s.
(A1) is a both-ends alkenyl group-containing linear polyorganosiloxane having an alkenyl group at both ends of the siloxane chain.
By virtue of containing (A1), the composition surely forms a stable three-dimensional structure by a crosslinking reaction during the curing of the composition, so that the elongation of a cured product of the composition can be controlled, ensuring excellent visibility.
Examples of C2-C6 alkenyl groups include a vinyl group, an allyl group, a 3-butenyl group and a 5-hexenyl group. Examples of C1-C6 alkyl groups include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group and a hexyl group. Examples of C6-C20 aryl groups include a phenyl group, a naphthyl group and an anthracenyl group.
From the viewpoint of facilitating the synthesis of the compound and causing no adverse effect on the fluidity of the composition before being cured and the heat resistance of a cured product of the composition, Ra1 is preferably a vinyl group. From the viewpoint of facilitating the synthesis of the compound and achieving excellent balance between, for example, the fluidity of the composition and the mechanical strength of the cured product, Rb1 is preferably a C1-C6 alkyl group, and especially preferably a methyl group. Accordingly, (A1) is preferably a polymethylvinylsiloxane having both ends blocked by dimethylvinylsiloxane units and having an intermediate unit comprising a dimethylsiloxane unit.
From the viewpoint of ensuring the stable liquid state of the composition, the viscosity of (A1) at 23° C. is 10 to 1,000,000 mPa·s, preferably 50 to 1,000,000 mPa·s, and more preferably 100 to 500,000 mPa·s. It is preferred that the weight average molecular weight of (A1), that is, n1 is controlled so that the viscosity of (A1) falls in the above range.
In the present specification, the viscosity is a value as measured using a rotational viscometer under conditions at 60 rpm and at 23° C. in accordance with JIS K 6249.
(2) (B1) Polyorganohydrogensiloxane represented by the formula (II)
(B1) is a polyorganohydrogensiloxane represented by the following formula (II):
##STR00006##
wherein:
each Rc1 is a hydrogen atom,
each Rb2 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n2 is a value such that the viscosity of the component (B1) at 23° C. is 0.1 to 300 mPa·s.
(B1) is a both-ends SiH group-containing linear polyorganosiloxane having at both ends of the siloxane chain a hydrogen atom bonded to a silicon atom.
(B1) is a component which extends the molecular chain between crosslinking sites to improve the elongation and stress relaxation property of a cured product of the composition.
From the viewpoint of facilitating the synthesis of the compound and achieving excellent balance between properties, such as the mechanical strength and the fluidity of the composition before being cured, Rb2 is preferably a C1-C6 alkyl group, and especially preferably a methyl group. Accordingly, (B1) is preferably a polymethyihydrogensiloxane having both ends blocked by dimethylhydrogensiloxane units and having an intermediate unit comprising a dimethylsiloxane unit.
The viscosity of (B1) at 23° C. is 0.1 to 300 mPa·s, preferably 1 to 200 mPa·s, more preferably 0.1 to 50 mPa·s, and especially preferably 1 to 30 mPa·s. It is preferred that the weight average molecular weight of (B1), that is, n2 is controlled so that the viscosity of (B1) falls in the above range.
(3) (B2) Crosslinkable polyorganohydrogensiloxane
(B2) is a polyorganohydrogensiloxane comprising a Rb32Rc2SiO1/2 unit (wherein each Rb3 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and Rc2 is a hydrogen atom) and a SiO4/2 unit, and having three or more hydrogen atoms bonded to silicon atoms per molecule.
(B2) is a component which contributes to forming a network structure of a cured product of the composition so as to control the hardness. (B2) may be either branched or cyclic. The number of Rc2, which is a hydrogen atom bonded to a silicon atom, is preferably 3 to 100 per molecule, and more preferably 3 to 50. From the viewpoint of, for example, facilitating the synthesis of the compound, Rb3 is preferably a C1-C6 alkyl group, and especially preferably methyl. Accordingly, (B2) is preferably a polyorganohydrogensiloxane having a cyclic siloxane skeleton formed from 3 to 5 SiO4/2 units, in which two Rb32Rc2SiO1/2 units are bonded to each SiO4/2 unit, such as [Rb32Rc2SiO1/2]8[SiO4/2]4 or [Rb32Rc2SiO1/2]10[SiO4/2]5.
The viscosity of (B2) is preferably 1 to 100 mPa·s, and more preferably 1 to 50 mPa·s.
(4) At least one member selected from the group consisting of (A2) an alkenyl group-containing polyorganosiloxane represented by the formula (III) and (B3) a linear polyorganohydrogensiloxane represented by the formula (IV)
(A2) is represented by the following formula (III):
##STR00007##
wherein:
each Ra2 is independently a C2-C6 alkenyl group,
each Rb4 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n3 is a value such that the viscosity of the component (A2) at 23° C. is 10 to 1,000,000 mPa·s,
and (B3) is represented by the following formula (IV):
##STR00008##
wherein:
Rc3 is a hydrogen atom,
each Rb5 is independently a C1-C6 alkyl group or a C6-C20 aryl group, and
n4 is a value such that the viscosity of the component (B3) at 23° C. is 0.1 to 300 mPa·s.
(A2) is a one-end alkenyl group-containing linear polyorganosiloxane having an alkenyl group only at one end of the siloxane chain, and (B3) is a one-end SiH group-containing linear polyorganosiloxane having only at one end of the siloxane chain a hydrogen atom bonded to a silicon atom. That is, (A2) and (B3) have only at one end of the siloxane chain a reactive group (i.e., an alkenyl group in (A2) or a hydrosilyl group (SiH) in (B3)). By virtue of containing (A2) and/or (B3), the composition can appropriately reduce the density of a three-dimensional structure formed by a crosslinking reaction during the curing of the composition, making it possible to improve the stress relaxation property of a cured product of the composition.
In the formula (III), Ra2 is synonymous with Ra1, including the preferred groups. Rb4 is synonymous with Rb1, including the preferred groups. Accordingly, (A2) is preferably polymethylvinylsiloxane having one end blocked by a dimethylvinylsiloxane unit and another end blocked by a trimethylsiloxane unit, and having an intermediate unit comprising a dimethylsiloxane unit.
From the viewpoint of ensuring the stable liquid state of the composition, the viscosity of (A2) at 23° C. is 10 to 1,000,000 mPa·s, preferably 50 to 1,000,000 mPa·s, and more preferably 100 to 500,000 mPa·s. It is preferred that the weight average molecular weight of (A2), that is, n3 is controlled so that the viscosity of (A2) falls in the above range.
In the formula (IV), from the viewpoint of facilitating the synthesis of the compound and achieving excellent balance between properties, such as the mechanical strength and the fluidity of the composition before being cured, Rb5 is preferably a C1-C6 alkyl group, and especially preferably a methyl group. Accordingly, (B3) is preferably a polymethylhydrogensiloxane having one end blocked by a dimethylhydrogensiloxane unit and another end blocked by a trimethylsiloxane unit, and having an intermediate unit comprising a dimethylsiloxane unit.
The viscosity of (B3) at 23° C. is 0.1 to 300 mPa·s, preferably 1 to 200 mPa·s, more preferably 1 to 50 mPa·s, and especially preferably 1 to 30 mPa·s. It is preferred that the weight average molecular weight of (B3), that is, n4 is controlled so that the viscosity of (B3) falls in the above range.
(5) (C) Platinum-based catalyst
(C) is a catalyst for accelerating an addition reaction between the alkenyl groups of (A1) and (A2) and the hydrosilyl groups (SiH) of (B1), (B2) and (B3). From the viewpoint of excellent catalytic activity, a compound of a metal atom of the platinum group such as platinum, rhodium or palladium is preferably used, and preferred are platinum compounds such as a chloroplatinic acid, a reaction product of a chloroplatinic acid and an alcohol, a platinum-olefin complex, a platinum-vinylsiloxane complex, a platinum-ketone complex and a platinum-phosphine complex; rhodium compounds such as a rhodium-phosphine complex and a rhodium-sulfide complex; and palladium compounds such as a palladium-phosphine complex, more preferred are platinum compounds, and especially preferred is a platinum-vinylsiloxane complex.
(Additive)
The composition can contain at least one additive selected from the group consisting of (D) a diluent, (E) a tackifier and (F) an inhibitor for the platinum-based catalyst in such an amount that the effects of the present invention are not damaged. The diluent (D), the tackifier (E) and the inhibitor (F) for the platinum-based catalyst may be used individually or in combination of two or more thereof, respectively.
When the composition contains a diluent (D), the viscosity of the composition is appropriately controlled. (D) is a silicone oil which does not contain an alkenyl group related to the curing reaction, and is preferably a polymethylsiloxane having both ends blocked by trimethylsiloxane units and having an intermediate unit comprising a dimethylsiloxane unit. The viscosity of (D) at 23° C. is preferably 1 to 5,000 mPa·s, and more preferably 5 to 1,000 mPa·s.
When the composition contains a tackifier (E), the adhesive strength between the composition and a substrate is further improved. Examples of tackifiers (E) include di-, tri- or tetra-alkoxysilanes such as tetramethoxysilane, tetraethoxysilane, tetrapropoxysilane, tetrabutoxysilane, methyltrimethoxysilane, dimethyldimethoxysilane, methyltriethoxysilane and dimethyldiethoxysilane; 3-glycidoxypropyl group-containing alkoxysilanes such as 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropyltriethoxysilane, 3-glycidoxypropyl(methyl)dimethoxysilane and 3-glycidoxypropyl(methyl)diethoxysilane; 2-(3,4-epoxycyclohexyl)ethyl group-containing alkoxysilanes such as 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltriethoxysilane and 2-(3,4-epoxycyclohexyl)ethyl(methyl)dimethoxysilane; alkenylalkoxysilanes such as vinyltrimethoxysilane, vinyltriethoxysilane, vinyltris(2-methoxyethoxy)silane, methylvinyldimethoxysilane, allyltrimethoxysilane, allyltriethoxysilane and methylallyldimethoxysilane; (meth)acryloxypropylalkoxysilanes such as 3-acryloxypropyltrimethoxysilane, 3-acryloxypropyltriethoxysilane, 3-acryloxypropyl(methyl)dimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropyltriethoxysilane and 3-methacryloxypropyl(methyl)dimethoxysilane; and organosilicon compounds such as a reaction product of 1,1,3,5,7-pentamethylcyclotetrasiloxane and 3-methacryloxypropyltrimethoxysilane.
As the organosilicon compound, for example, specifically, there can be mentioned an organosilicon compound having a side chain represented by the following formula:
##STR00009##
wherein each of Q1 and Q2 independently represents an alkylene group, preferably a C1-C4 alkylene group, and R3 represents a C1-C4 alkyl group.
With respect to the organosilicon compound, preferred are compounds shown below.
##STR00010##
When the composition contains an inhibitor (F) for the platinum-based catalyst, the curing rate of the composition is appropriately controlled. Examples of inhibitors (F) for the platinum-based catalyst include one or more members selected from the group consisting of an acetylenic silane, an olefinic siloxane having a 3-hydroxy-2-propenyl (OH—C(CH3)2—CH═CH—) group, and a vinylorganoxiloxane. These inhibitors for the platinum-based catalyst are described in Japanese Patent Application Kokai Publication No. S52-47053.
(Formulation and Others)
In the composition, the amount of (A2) contained is 0 to 60 parts by weight, relative to 100 parts by weight of the total of (A1) and (A2). When the amount of (A2) contained is more than 60 parts by weight, relative to 100 parts by weight of the total of (A1) and (A2), the fast-curing property of the composition at room temperature is poor. The amount of (A2) contained, relative to 100 parts by weight of the total of (A1) and (A2), is preferably 1 to 60 parts by weight, more preferably 5 to 52 parts by weight, further preferably 5 to 37 parts by weight, and especially preferably 17 to 37 parts by weight. When the amount of (A2) contained is 5 to 37 parts by weight, relative to 100 parts by weight of the total of (A1) and (A2), the adhesive strength is likely to be further improved, and, when the amount of (A2) contained is 17 to 37 parts by weight, it is likely that the elongation of a cured product of the composition as well as the adhesive strength are further improved, so that the stress relaxation property is further improved.
In the composition, the value of (HB1+HB2+HB3)/(ViA1+ViA2) is 0.6 to 2.2. When the value of (HB1+HB2+HB3)/(ViA1+ViA2) is less than 0.6, the composition is cured slowly or is not cured. When the value of (HB1+HB2+HB3)/(ViA1+ViA2) is more than 2.2, a cured product of the composition has poor reliability properties under high-temperature and high-humidity conditions.
A preferred range of the (HB1+HB2+HB3)/(ViA1+ViA2) is from 0.6 to 1.4, from 0.6 to 1.00 or from 0.6 to 0.99, and may be from 0.6 to 0.8 or from 0.7 to 0.8. In the case where the value of (HB1+HB2+HB3)/(ViA1+ViA2) is in the above preferred range, even when a cured product of the composition is heated at a high temperature (for example, heated at 100 to 180° C.), the cured product is likely to have a small change ratio of the flexibility. That is, even when the composition is cured and then further heated at a high temperature, it is likely that there is obtained a cured product which can appropriately relax an external stress to surely obtain a resistance to deformation. Such a cured product has more excellent cold heat cycle reliability. Further, when the value of (HB1+HB2+HB3)/(ViA1+ViA2) is 0.8 or less, a cured product of the composition is likely to have higher elongation.
(Preferred Formulation and Others)
The composition preferably satisfies the followings. In the following description, the wording “when the composition contains (A2)” indicates “when the composition contains (A2) and (B3)”, and preferably indicates “when the composition contains (A2) and does not contain (B3)”. The wording “when the composition contains (B3)” indicates “when the composition contains (A2) and (B3)”, and preferably indicates “when the composition contains (B3) and does not contain (A2)”.
When the composition contains (A2), in the composition, the value of (HB1+HB2)/(ViA1+ViA2) is preferably 0.6 to 2.2. When the value of (HB1+HB2)/(ViA1+ViA2) is 0.6 or more, the fast-curing property of the composition is improved. When the value of (HB1+HB2)/(ViA1+ViA2) is 2.2 or less, a cured product of the composition is improved in the reliability properties under high-temperature and high-humidity conditions. The value of (HB1+HB2)/(ViA1+ViA2) is more preferably 0.6 to 1.00, further preferably 0.6 to 0.99, still further preferably 0.6 to 0.8, and especially preferably 0.7 to 0.8. In the case where the value of (HB1+HB2)/(ViA1+ViA2) is in the above preferred range, even when a cured product of the composition is heated at a high temperature, the cured product is likely to have a small change ratio of the flexibility. Further, when the value of (HB1+HB2)/(ViA1+ViA2) is 0.8 or less, a cured product of the composition is likely to have higher elongation.
When the composition contains (A2), from the viewpoint of facilitating control of the density of a three-dimensional structure formed by a crosslinking reaction during the curing of the composition, with respect to (A1) and (A2), it is preferred that a combination of (A1) having a high viscosity (for example, 5,000 to 20,000 mPa·s) and (A2) having a low viscosity (for example, 50 to 1,000 mPa·s) is contained.
When the composition contains (A2), in the composition, the value of HB1/(HB1+HB2) is preferably 0.2 to 0.9, more preferably 0.2 to 0.8, and especially preferably 0.3 to 0.8, since it is likely that a cured product of the composition can be obtained, which has a further improved adhesive strength, excellent transparency and less yellowing.
As apparent from the above, when the composition contains (A2), in the composition, it is preferred that the amount of (A2) is 5 to 37 parts by weight, relative to 100 parts by weight of the total of (A1) and (A2), the value of (HB1+HB2)/(ViA1+ViA2) is 0.6 to 0.99, and the value of HB1/(HB1+HB2) is 0.3 to 0.8.
When the composition contains (B3), in the composition, the value of (HB1+HB2+HB3)/ViA1 is preferably 0.6 to 2.5. When the value of (HB1+HB2+HB3)/ViA1 is 0.6 or more, the fast-curing property of the composition is improved. When the value of (HB1+HB2+HB3)/ViA1 is 2.5 or less, the occurrence of foaming in a cured product of the composition under high-temperature and high-humidity conditions can be satisfactorily suppressed. The value of (HB1+HB2+HB3)/ViA1 is more preferably 0.6 to 2.2, further preferably 0.6 to 2.0, still further preferably 0.6 to 1.4, still further preferably 0.6 to 0.99, and especially preferably 0.8 to 0.99. When the value of (HB1+HB2+HB3)/ViA1 is preferably 0.6 to 1.4, and more preferably 0.6 to 0.99, the cured product even after heated at a high temperature is likely to have a small change ratio of the flexibility.
When the composition contains (B3), in the composition, the value of HB3/(HB1+HB2+HB3) is preferably 0.1 to 0.9, more preferably 0.15 to 0.5, and especially preferably 0.2 to 0.4. When the value of HB3/(HB1+HB2+HB3) is 0.1 or more, the density of a three-dimensional structure formed by a crosslinking reaction during the curing of the composition can be appropriately reduced, so that the stress relaxation property of a cured product of the composition is further improved. When the value of HB3/(HB1+HB2+HB3) is 0.9 or less, the fast-curing property of the composition is improved.
When the composition contains (B3), in the composition, the value of HB2/(HB1+HB2+HB3) is preferably 0.1 to 0.9, more preferably 0.1 to 0.7, and especially preferably 0.15 to 0.55. When the value of HB2/(HB1+HB2+HB3) is 0.1 or more, the fast-curing property of the composition is improved. When the value of HB2/(HB1+HB2+HB3) is 0.9 or less, the cured product obtained after heated at a high temperature is improved in flexibility.
From the fact that the cured product even after heated at a high temperature is likely to have excellent stress relaxation property, it is preferred that the composition contains a combination of (A2) and (B3).
When the composition contains (A2), it is preferred that the composition contains an alkenyl group-containing polyorganosiloxane comprising only (A1) and (A2), and, in this case, the composition does not contain an alkenyl group-containing polyorganosiloxane other than (A1) and (A2). When the composition does not contain (A2), it is preferred that the composition contains an alkenyl group-containing polyorganosiloxane comprising only (A1), and, in this case, the composition does not contain an alkenyl group-containing polyorganosiloxane other than (A1).
When the composition contains (B3), it is preferred that the composition contains a polyorganohydrogensiloxane comprising only (B1), (B2) and (B3), and, in this case, the composition does not contain a polyorganohydrogensiloxane other than (B1), (B2) and (B3). When the composition does not contain (B3), it is preferred that the composition contains a polyorganohydrogensiloxane comprising only (B1) and (B2), and, in this case, the composition does not contain a polyorganohydrogensiloxane other than (B1) and (B2).
Therefore, when the composition contains (A2) and (B3), it is preferred that the composition contains an alkenyl group-containing polyorganosiloxane comprising only (A1) and (A2), and a polyorganohydrogensiloxane comprising only (B1), (B2) and (B3). In this case, the composition does not contain an alkenyl group-containing polyorganosiloxane other than (A1) and (A2), and a polyorganohydrogensiloxane other than (B1) and (B2).
From the viewpoint of ensuring an appropriate curing rate, the amount of (C) contained in the composition is preferably 0.1 to 1,000 ppm by weight, and more preferably 0.5 to 200 ppm by weight, based on the total weight of (A1) and (A2), in terms of a metal atom of the platinum group.
The amount of (D) contained in the composition, relative to 100 parts by weight of the total of (A1) and (A2) in the composition, is preferably 50 parts by weight or less, more preferably 30 parts by weight or less, and further preferably 20 parts by weight or less.
The total amount of the additives contained in the composition, relative to 100 parts by weight of the total of (A1), (B1), (B2), and at least one member selected from the group consisting of (A2) and (B3) in the composition, is preferably 100 parts by weight or less, more preferably 30 parts by weight or less, and further preferably 20 parts by weight or less.
The composition can be obtained by blending together (A1), (B1), (B2), at least one member selected from the group consisting of (A2) and (B3), (C), and an arbitrary component. From the viewpoint of easily forming the composition in a uniform state to obtain a transparent cured product, it is preferred that the composition is a two-part composition comprising a first portion which contains “a combination of (A1), (A2) and (C)” or “a combination of (A1) and (C)” and which does not contain (B1), (B2) and (B3), and a second portion which contains (A1), (B1), (B2), and at least one member selected from the group consisting of (A2) and (B3) and which does not contain (C). It is preferred that the first portion and the second portion are mixed each other to form a uniform composition. The arbitrary component can be appropriately added to the composition.
From the viewpoint of the spreadability of the composition being applied, the composition preferably has a viscosity at 23° C. of 100,000 mPa·s or less, and more preferably 50 to 50,000 mPa·s. When the composition is a two-part composition comprising a first portion and a second portion, each viscosity of the first portion and the second portion is preferably 10 to 100,000 mPa·s, more preferably 50 to 50,000 mPa·s, and especially preferably 100 to 20,000 mPa·s.
The composition may be a room temperature curing composition which is curable at room temperature (for example, at 5 to 40° C.). Alternatively, the composition may be a thermosetting resin composition which is cured by heating. The heating temperature can be, for example, higher than 40 to 80° C., and is preferably 60 to 70° C. The heating time can be, for example, 0.5 to 10 hours, and is preferably 0.5 to 2 hours, more preferably 0.5 to 60 minutes, and especially preferably one to less than 30 minutes.
The composition can be used as a sealing agent for an image display device, which comprises the composition. The sealing agent for an image display device is disposed between an image display part and a protective portion and cured by heating, making it possible to seal the image display part and the protective portion. The composition is preferably for adhering a base portion having an image display part for an image display device to a light-transmitting protective portion.
The composition can be suitably used in an image display device, and is particularly preferred as a resin disposed between a protective portion and an image display part for an image display device of a flat panel type. Accordingly, the present invention is directed to an image display device using the composition, specifically, an image display device which has a base portion having an image display part for the image display device and a light-transmitting protective portion, wherein the base portion is adhered to the protective portion using the composition. Specifically, the present invention is directed to an image display device produced by a method for producing an image display device, wherein the method comprises the steps of applying the composition onto a protective panel constituting a transparent protective portion formed from, for example, an optical plastic, then laminating an image display panel constituting an image display part on the protective panel, and heating the composition.
Hereinbelow, the present invention will be described in more detail with reference to the following Examples and Comparative Examples, which should not be construed as limiting the scope of the present invention. The values for amount are indicated in “part(s) by weight” or “% by weight” unless otherwise specified.
Two-part compositions each comprising (A) and (B) in the Examples and Comparative Examples were individually prepared by mixing together the components having the formulations shown in Tables 1 to 9. In Tables 1 to 9, the “Mix” means an amount relative to the total of “(A)” and “(B)”.
The components used are shown below. The characters mean the followings.
M: (CH3)3SiO1/2
MH: H(CH3)2SiO1/2
MV: CH2═CH(CH3)2SiO1/2
D: (CH3)2SiO2/2
DH: H(CH3)SiO2/2
Q: SiO4/2 (tetrafunctional)
A1-1: Polymethylvinylsiloxane having both ends blocked by MV units and having an intermediate unit comprising a D unit (Viscosity at 23° C.: 12,200 mPa·s)
a2: Mixture of items (1) to (3) below. In the mixture: A1-2: 25% by weight; A2: 50% by weight; and D1: 25% by weight.
(1) A1-2: Polymethylvinylsiloxane having both ends blocked by MV units and having an intermediate unit comprising a D unit (Viscosity at 23° C.: 600 mPa·s)
(2) A2: Polymethylvinylsiloxane having one end blocked by an MV unit and another end blocked by an M unit and having an intermediate unit comprising a D unit (Viscosity at 23° C.: 600 mPa·s)
(3) D1: Polydimethylsiloxane having both ends blocked by M units and having an intermediate unit comprising a D unit (Viscosity at 23° C.: 600 mPa·s)
B1: Linear polymethylhydrogensiloxane represented by MHD20MH (Viscosity at 23° C.: 20 mPa·s)
B2: Crosslinkable polymethylbydrogensiloxane having an average unit formula represented by [H(CH3)2SiO1/2]s[SiO4/2]4 (Effective hydrogen content: 1%)
b3: Mixture of items (4) to (6) below. In the mixture: B1-2: 25% by weight; B3: 50% by weight; and D2: 25% by weight.
(4) B1-2: Linear polymethylhydrogensiloxane represented by MHD20MH (Viscosity at 23° C.: 20 mPa·s)
(5) B3: Linear polymethylhydrogensiloxane represented by MHD20M (Viscosity at 23° C.: 20 mPa·s)
(6) D2: Linear polydimethylsiloxane represented by MD20M (Viscosity at 23° C.: 20 mPa·s)
B4: Linear polymethylhydrogensiloxane represented by MDH17D83M (Viscosity at 23° C.: 120 mPa·s)
C1: Complex which is obtained by heating chloroplatinic acid and 1,3-divinyl-1,1,3,3-tetramethyldisiloxane in a molar ratio of 1:4, and which has a platinum content of 4.9% by weight.
The evaluation of physical properties was conducted as descried below. The results are shown in Tables 1 to 9.
(1) Viscosity
Using a rotational viscometer (Vismetron VDA-L) (manufactured by Shibaura Systems Co., Ltd.), a viscosity (mPa·s) at 23° C. was measured. Other procedures were made in accordance with JIS K 6249 to conduct the measurement.
(2) Tack-Free Time
The composition (A) and the composition (B) were extruded in a volume ratio of 1:1, and while mixing together the extruded compositions using a mixing nozzle, 5 g of the resultant mixture was placed on a flat plate. The time at which the two compositions were in contact each other was set as 0, and a finger which had been cleaned with ethyl alcohol was lightly put on the surface of the mixture, and a period of time required until any sample did not adhere to the finger was determined as a tack-free time.
(3) Penetration
40 ml of an uncured silicone gel composition was placed in a heat-resistant glass beaker having a capacity of 50 ml and heated at 60° C. for 30 minutes to be cured, obtaining a silicone gel. After cooling the silicone gel to room temperature, a penetration (1) before heating treatment was measured in accordance with JIS K 6249 using a ¼ cone. Separately, 40 ml of an uncured silicone gel composition was placed in a heat-resistant glass beaker having a capacity of 50 ml and heated at 60° C. for 30 minutes to be cured, obtaining a silicone gel before heating treatment. Then, the resultant silicone gel was subjected to heating treatment at 150° C. for one hour, obtaining a silicone gel after heating treatment. After cooling the silicone gel to room temperature, a penetration (2) after heating treatment was measured in accordance with JIS K 6249 using a ¼ cone. A penetration change ratio in the heating treatment was determined from the formula (1) shown below. A large penetration means that the cured product has high flexibility and thus has excellent stress relaxation property. A small penetration change ratio means that the cured product after heating treatment has a small change ratio of the flexibility.
Penetration change ratio=(Penetration (1) before heating treatment−Penetration (2) after heating treatment)÷Penetration (1) before heating treatment Formula (1)
(4) Yellow Index (YI)
As substrates, two glass plates (5 cm×5 cm×1 mm thickness) were used. A spacer was preliminarily disposed between the substrates so that the thickness of the composition became 200 μm. The two glass plates were laminated through the composition so that the composition had a size of 50 mm×50 mm and had a thickness of 200 μm, obtaining a laminate. The laminate was subjected to heat treatment at 25° C. for 30 minutes and at 70° C. for 30 minutes, obtaining an adhesive body having the two substrates adhered to each other through a cured product of the composition. The adhesive body was rendered in a state at 25° C., and then a yellow index, which is an index of the degree of color change, was measured. A yellow index was measured using a spectrophotometer (CM-3500d, manufactured by Konica Minolta, Inc.).
(5) Haze
A specimen was prepared in the same manner as in “(4) Yellow index”. With respect to the prepared specimen, a haze was measured in accordance with JIS K 7105 using Haze meter NDH5000 (manufactured by Nippon Denshoku Industries Co., Ltd.).
(6) b* (D65)
A specimen was prepared in the same manner as in “(4) Yellow index”. With respect to the prepared specimen, a b* (D65) was measured.
(7) Foaming
(7-1) Preparation of Specimen (1)
A specimen was prepared in the same manner as in “(4) Yellow index”.
(7-2) Preparation of Specimen (2)
As substrates, two glass plates (5 cm×5 cm×1 mm thickness) were used. A spacer was preliminarily disposed between the substrates so that the thickness of the composition became 200 μm. The two glass plates were laminated through the composition so that the composition had a size of 50 mm×50 mm and had a thickness of 200 μm, obtaining a laminate. The laminate was subjected to heat treatment at 60° C. for 30 minutes, obtaining an adhesive body having the two substrates adhered to each other through a cured product of the composition. The obtained adhesive body was used as a specimen.
(7-3) Foaming Test
The prepared specimens were individually placed in a thermo-hygrostat at 85° C. and at 85% RH for 500 hours, and then visually examined as to whether or not the resin had therein air bubbles. In the tables below, the rating “⅓ Foaming” indicates that air bubbles were confirmed in one specimen among the three specimens.
(8) Glass/Glass Shear Adhesive Strength (MPa) and Elongation (%)
Two glass plates (length: 80 mm; width: 25 mm; thickness: 2 mm) arranged in parallel were laminated through a composition so that the composition had a length of 25 mm, a width of 10 mm and a thickness of 150 μm, and heated at 60° C. for 30 minutes to cure the composition, preparing a test specimen for a shear adhesive strength measurement. The obtained test specimen was pulled in the direction perpendicular to the adhesive surface at a speed of 10 mm/minute to measure an adhesive strength and an elongation.
(9) Cold Heat Cycle Test
As substrates, a glass plate (14 cm×10 cm×1 mm thickness) and PMMA (manufactured by Kuraray Co., Ltd.) (16 cm×11 cm×1 mm thickness) were used. The substrates were laminated through a composition so that the thickness of the composition became 400 μm using a spacer preliminarily disposed between the substrates, obtaining a laminate. The laminate was subjected to heat treatment at 60° C. for 30 minutes, obtaining an adhesive body having the two substrates adhered to each other through a cured product of the composition. The adhesive body was placed in a cold heat cycle machine having one cycle at −40° C. for 30 minutes and at 85° C. for 30 minutes and retained in the machine for 100 cycles. The adhesive body was removed from the machine and visually examined as to whether or not peeling (separation of the substrates) and a crack in the resin occurred. An adhesive body which has suffered no peeling and no formation of a crack in the resin in the cold heat cycle test has excellent reliability under high-temperature and high-humidity conditions. In the tables below, the rating “⅖” indicates that peeling or a crack in the resin was confirmed in two specimens among the five specimens.
The results are summarized below. In Comparative Example 7, HB2 is the number for the hydrogen atoms bonded to the silicon atoms of B4.
TABLE 1
Example 1
Example 2
Example 3
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1-1
45.988
52.08
49.034
45.988
54.5
50.244
45.988
56.94
51.464
a2
54
38
46
54
38
46
54
38
46
B1
9
4.5
6.8
3.4
4.6
2.3
B2
0.92
0.46
0.7
0.35
0.46
0.23
C1
0.012
0.008
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
100
100
100
Pt Content (ppm)
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 + ViA2)
2.00
1.50
0.99
HB1 + HB2 (mmol)
10.85
8.22
5.50
ViA1 + ViA2 (mmol)
5.42
5.49
5.56
Weight of A2, relative to 100 parts of
28
27
27
total of A1 and A2
HB1/(HB1 + HB2)
0.58
0.58
0.59
Viscosity (mPa · s)
3350
3240
3350
3580
3350
4060
Tack-free time
2′20
3′20
6′20
Penetration (1) before heating treatment
39
42
28
Penetration (2) after heating treatment
14
16
26
Penetration change ratio (%)
84
62
7
Haze
0.01
0.02
0.03
YI
0.28
0.07
0.08
b *
0.17
0.07
0.06
Foaming (Specimen 1)
No
No
No
Cold heat cycle (100 Cycles)
0/5
0/5
0/5
Glass/glass shear adhesive strength (MPa)
0.18
0.23
0.28
Glass/glass shear elongation(%)
58
64
57
TABLE 2
Example 4
Example 5
Example 6
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1-1
45.988
57.92
51.954
45.988
58.46
52.224
45.988
59.52
52.754
a2
54
38
46
54
38
46
54
38
46
B1
3.7
1.85
3.2
1.6
1.58
0.79
B2
0.38
0.19
0.34
0.17
0.9
0.45
C1
0.012
0.006
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
100
100
100
Pt Content (ppm)
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 + ViA2)
0.80
0.70
0.98
HB1 + HB2 (mmol)
4.47
3.92
5.52
ViA1 + ViA2 (mmol)
5.59
5.60
5.64
Weight of A2, relative to 100 parts of
27
27
26
total of A1 and A2
HB1/(HB1 + HB2)
0.58
0.58
0.20
Viscosity (mPa · s)
3350
4260
3350
4400
3350
4600
Tack-free time
9′00
12′00
3′30
Penetration (1) before heating treatment
64
91
13
Penetration (2) after heating treatment
54
77
10
Penetration change ratio (%)
16
15
23
Haze
0.04
0.04
0.04
YI
0.21
0.21
0.23
b *
0.13
0.13
0.15
Foaming (Specimen 1)
No
No
No
Cold heat cycle (100 Cycles)
0/5
0/5
0/5
Glass/glass shear adhesive strength (MPa)
0.1
0.03
0.2
Glass/glass shear elongation(%)
72
80
32
TABLE 3
Example 7
Example 8
Example 9
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1-1
45.988
54.89
50.439
89.988
84.93
87.459
19.988
14.94
17.464
a2
54
38
46
10
10
10
80
80
80
B1
7
3.5
4.6
2.3
4.6
2.3
B2
0.11
0.055
0.47
0.235
0.46
0.23
C1
0.012
0.006
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
100
100
100
Pt Content (ppm)
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 + ViA2)
1.00
0.98
1.00
HB1 + HB2 (mmol)
5.47
5.55
5.50
ViA1 + ViA2 (mmol)
5.50
5.63
5.49
Weight of A2, relative to 100 parts of
27
5
52
total of A1 and A2
HB1/(HB1 + HB2)
0.90
0.58
0.59
Viscosity (mPa · s)
3350
3680
10400
8340
1570
1170
Tack-free time
12′00
3′20
11′00
Penetration (1) before heating treatment
124
11
90
Penetration (2) after heating treatment
112
8
84
Penetration change ratio (%)
10
27
7
Haze
0.04
0.05
0.01
YI
0.24
0.28
0.1
b *
0.13
0.17
0.07
Foaming (Specimen 1)
No
No
No
Cold heat cycle (100 Cycles)
0/5
0/5
0/5
Glass/glass shear adhesive strength (MPa)
0.02
0.2
0.05
Glass/glass shear elongation (%)
110
36
43
TABLE 4
Comparative Example 1
Comparative Example 2
Comparative Example 3
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1-1
45.988
59.47
52.729
45.988
49.9
47.944
45.988
60.84
53.414
a2
54
38
46
54
38
46
54
38
46
B1
2.3
1.15
11
5.5
0
B2
0.23
0.115
1.1
0.55
1.16
0.58
B4
C1
0.012
0.006
0.012
0.006
0.012
0.008
Total
100
100
100
100
100
100
100
100
100
Pt Content (ppm)
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 + ViA2)
0.49
2.45
1.00
HB1 + HB2 (mmol)
2.75
13.15
5.68
ViA1 + ViA2 (mmol)
5.63
5.36
5.67
Weight of A2, relative to 100 parts of
26
28
26
total of A1 and A2
HB1/(HB1 + HB2)
0.59
0.59
0.00
Viscosity (mPa · s)
3350
4800
3350
2870
3350
4930
Tack-free time
30 min or more
2′00
3′00
Penetration (1) before heating treatment
Uncured
38
6
Penetration (2) after heating treatment
Uncured
14
3
Penetration change ratio (%)
Uncured
63
50
Haze
Uncured
0.02
0.04
YI
Uncured
0.27
0.27
b *
Uncured
0.16
0.17
Foaming (Specimen 1)
Uncured
3/3 Foaming
No
Cold heat cycle (100 Cycles)
Uncured
0/5
0/5
Glass/glass shear adhesive strength(MPa)
Uncured
0.25
0.31
Glass/glass shear elongation (%)
Uncured
60
8
TABLE 5
Comparative Example 4
Comparative Example 5
Comparative Example 6
Comparative Example 7
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1-1
45.998
54.2
50.094
99.988
94.82
97.404
45.988
55.7
50.844
a2
54
38
46
99.988
94.93
97.459
54
38
46
B1
7.8
3.9
4.7
2.35
4.8
2.3
4.6
2.3
B2
0.48
0.24
0.47
0.235
B4
1.7
0.85
C1
0.012
0.006
0.012
0.006
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
100
100
100
100
100
100
Pt Content (ppm)
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 +
1.00
1.00
1.60
1.02
ViA2)
HB1 + HB2 (mmol)
5.50
5.67
8.74
5.62
ViA1 + ViA2 (mmol)
5.48
5.65
5.46
5.52
Weight of A2, relative to 100
27
0
67
27
parts of total of A1 and A2
HB1/(HB1 + HB2)
1.00
0.58
0.37
0.58
Viscosity (mPa · s)
3350
3570
12680
10400
840
730
3350
3800
Tack-free time
30 min
2′30
30 min
30 min
or more
or more
or more
Penetration (1) before
Uncured
6
Uncured
30
heating treatment
Penetration (2) after
Uncured
3
Uncured
20
heating treatment
Penetration change ratio (%)
Uncured
50
Uncured
33
Haze
Uncured
0.04
Uncured
0.08
YI
Uncured
0.19
Uncured
0.13
b *
Uncured
0.13
Uncured
0.09
Foaming (Specimen 1)
Uncured
No
Uncured
1/3 Foaming
Cold heat cycle (100 Cycles)
Uncured
0/5
Uncured
0/5
Glass/glass shear adhesive
Uncured
0.32
Uncured
0.32
strength(MPa)
Glass/glass shear elongation
Uncured
8
Uncured
46
(%)
TABLE 6
Example 10
Example 11
Example 12
Example 13
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1-1
99.988
95
97.494
99.988
89.45
94.719
99.988
90.8
95.394
99.988
83.5
91.814
B1-1
0
0
0
0
B2
0.6
0.3
0.35
0.175
0.6
0.3
0.35
0.18
b3
4.4
2.2
10.2
5.1
8.6
4.3
16
8
B4
C1
0.012
0.006
0.012
0.006
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
100
100
100
100
100
100
Pt Content (ppm)
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 + ViA2)
0.60
0.70
0.80
0.99
HB1 + HB2 + HB3 (mmol)
4.31
4.89
5.62
6.75
ViA1 (mmol)
7.21
7.01
7.06
6.79
Weight of A2, relative to 100 parts of
0
0
0
0
total of A1 and A2
HB2/(HB1 + HB2 + HB3)
0.68
0.35
0.52
0.26
HB3/(HB1 + HB2 + HB3)
0.16
0.32
0.24
0.37
Viscosity (mPa · s)
3600
3070
3600
2500
3600
2640
3600
2050
Tack-free time
4′40
7′30
3′30
4′40
Penetration (1) before heating treatment
52
102
32
59
Penetration (2) after heating treatment
47
95
27
53
Penetration change ratio ((1) − (2))/(1)
9.6
6.9
15.6
10.2
Haze
0.01
0.01
0.03
0.05
YI
0.03
0.03
0.04
0.03
b *
0.02
0.01
0.03
0.01
Foaming (Specimen 2)
No
No
No
No
Cold heat cycle (100 Cycles)
0/5
0/5
0/5
0/5
Glass/glass shear adhesive strength(MPa)
0.26
0.04
0.43
0.26
Glass/glass shear elongation (%)
28
30
26
33
TABLE 7
Example 14
Example 15
Example 16
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1
99.98
80.8
90.37
99.988
82.42
91.204
99.988
75.8
87.894
B1-1
0
5.7
2.85
0
B2
0.44
0.22
0.38
0.19
1.2
0.6
b3
18.8
9.4
11.5
5.75
23
11.5
B4
C1
0.02
0.01
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
100
100
100
Pt Content (ppm)
9.8
0.0
4.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 + ViA2)
1.20
1.40
2.01
HB1 + HB2 + HB3 (mmol)
8.01
9.46
13.04
ViA1 (mmol)
6.69
6.75
6.50
Weight of A2, relative to 100 parts of
0
0
0
total of A1 and A2
HB2/(HB1 + HB2 + HB3)
0.27
0.20
0.45
HB3/(HB1 + HB2 + HB3)
0.37
0.19
0.27
Viscosity (mPa · s)
3600
1900
3600
2000
3600
1580
Tack-free time
4′00
3′30
2′00
Penetration (1) before heating treatment
58
58
20
Penetration (2) after heating treatment
48
21
12
Penetration change ratio ((1) − (2))/(1)
17.2
63.8
40.0
Haze
0.01
0.01
0.04
YI
0.08
0.05
0.06
b *
0.04
0.02
0.04
Foaming (Specimen 2)
No
No
No
Cold heat cycle (100 Cycles)
0/5
0/5
0/5
Glass/glass shear adhesive strength (MPa)
0.22
0.29
0.24
Glass/glass shear elongation (%)
29
37
16
TABLE 8
Comparative
Comparative
Comparative
Comparative
Example 8
Example 9
Example 10
Example 11
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
(A)
(B)
Mix
A1
99.988
98.8
99.394
99.988
65.3
82.644
99.988
99.6
99.794
99.988
91
95.494
B1-1
0
0
8
4
8
4
B2
0.2
0.1
1.7
0.85
0.4
0.2
0
b3
1
0.5
33
16.5
0
0
B4
0
1
0.5
C1
0.012
0.006
0.012
0.006
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
100
108
104
100
100
100
Pt Content (ppm)
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
5.9
0.0
2.9
(HB1 + HB2 + HB3)/(ViA1 + ViA2)
0.18
3.04
1.03
1.00
HB1 + HB2 + HB3 (mmol)
1.29
18.61
7.60
7.04
ViA1 (mmol)
7.36
6.12
7.38
7.07
Weight of A2, relative to 100
0
0
0
0
parts of total of A1 and A2
HB2/(HB1 + HB2 + HB3)
0.76
0.45
—
—
HB3/(HB1 + HB2 + HB3)
0.12
0.28
0.00
0.00
Viscosity (mPa · s)
3600
3500
3600
1060
3600
2840
3600
2600
Tack-free time
30 min
1′20
5′00
30 min
or more
or more
Penetration (1) before
Uncured
22
7
18
heating treatment
Penetration (2) after
Uncured
8
3
7
heating treatment
Penetration change ratio
Uncured
63.6
57.1
61.1
((1) − (2))/(1)
Haze
Uncured
0.03
0.03
0.02
YI
Uncured
0.03
0.06
0.03
b *
Uncured
0.02
0.02
0.02
Foaming (Specimen 2)
Uncured
3/3 Foaming
No
1/3 Foaming
Cold heat cycle (100 Cycles)
Uncured
5/5
5/5
2/5
Glass/glass shear adhesive
Uncured
0.21
0.24
0.23
strength(MPa)
Glass/glass shear elongation(%)
Uncured
15
11
17
TABLE 9
Example 17
Example 18
(A)
(B)
Mix
(A)
(B)
Mix
A1-1
45.988
55.73
50.859
89.988
83.4
86.694
a2
54
38
46
10
10
10
B1-1
1.9
0.95
2
1
B2
0.47
0.235
0.5
0.25
b3
3.9
1.95
4.1
2.05
C1
0.012
0.006
0.012
0.006
Total
100
100
100
100
100
100
Pt Content (ppm)
5.9
0
2.9
2.9
(HB1 + HB2 + HB3)/
0.98
0.97
(ViA1 + ViA2)
HB1 + HB2 + HB3)/ViA1
1.25
1.02
HB1 + HB2 + HB3
4.81
5.09
(mmol)
ViA1 + ViA2 (mmol)
4.91
5.23
ViA1 (mmol)
3.86
5.00
HB1 + HB2 (mmol)
4.21
4.45
(HB1 + HB2)/
0.86
0.85
(ViA1 + ViA2)
Weight of A2, relative
27
5
to 100 parts of
total of A1 and A2
HB1/(HB1 + HB2)
0.43
0.43
HB2/(HB1 + HB2 + HB3)
0.5
0.5
HB3/(HB1 + HB2 + HB3)
0.13
0.13
Viscosity mPa
3630
4120
11060
4200
Tack-free time
10′00
5′00
Penetration (1) before
46
12
heating treatment
Penetration (2) after
44
12
heating treatment
Penetration change
4.3
0.0
ratio ((1) − (2))/(1)
Haze
0.05
0.05
YI
0.04
0.1
b *
0.03
0.05
Foaming (Specimen 2)
No
No
Cold heat cycle
0/5
0/5
(100 Cycles)
Glass/glass shear
0.35
0.53
adhesive strength(MPa)
Glass/glass shear
30
24
elongation(%)
The compositions in Examples 1 to 9 contain (A2) and do not contain (B3). The compositions in Examples 10 to 16 contain (B3) and do not contain (A2). The compositions in Examples 17 and 18 contain both (A2) and (B3).
Each of the compositions in the Examples had excellent fast-curing property at room temperature, and the composition after cured had high elongation, excellent stress relaxation property, excellent reliability properties under high-temperature and high-humidity conditions, and excellent cold heat cycle reliability.
A comparison was made between Examples 1 and 2 and Examples 3 to 5. With respect to the cured products having almost the same weight of (A2), relative to 100 parts by weight of the total of (A1) and (A2), and having almost the same value of HB1/(HB1+HB2), the cured products in Examples 3 to 5, in which the value of (HB1+HB2+HB3)/(ViA1+ViA2) (i.e., (HB1+HB2)/(ViA1+ViA2)) was 0.99 or less, had a small penetration change ratio, and excellent stress relaxation property even after the heating treatment. Further, a comparison was made between Example 3 and Examples 4 and 5. The cured products in Examples 4 and 5, in which the value of (HB1+HB2+HB3)/(ViA1+ViA2) (i.e., (HB1+HB2)/(ViA1+ViA2)) was 0.8 or less, had a higher elongation.
A comparison was made between Example 3 and Examples 6 and 7. With respect to the cured products having almost the same weight of (A2), relative to 100 parts by weight of the total of (A1) and (A2), and having almost the same value of (HB1+HB2+HB3)/(ViA1+ViA2) (i.e., (HB1+HB2)/(ViA1+ViA2)), the cured product in Example 3, in which the value of HB1/(HB1+HB2) was in an especially preferred range, was further improved in the adhesive strength. Further, with respect to the compositions in Examples 6 and 7 in which the value of (HB1+HB2+HB3)/(ViA1+ViA2) (i.e., (HB1+HB2)/(ViA1+ViA2)) is changed to be almost the same as that in the compositions in Examples 4 and 5, it is presumed that cured products obtained from the compositions in Examples 4 and 5 have a further improved adhesive strength. A comparison was made between Examples 3 to 8 and Example 9. With respect to the cured products having almost the same value of HB1/(HB1+HB2) and having almost the same value of (HB1+HB2+HH3)/(ViA1+ViA2) (i.e., (HB1+HB2)/(ViA1+ViA2)), in the case where the weight of (A2), relative to 100 parts by weight of the total of (A1) and (A2), was in a further preferred range, the adhesive strength was further improved, and, in the case where the weight of (A2) was in an especially preferred range, the adhesive strength was further improved and the elongation was further improved.
In Comparative Example 1, the value of (HB1+HB2+HB3)/(ViA1+ViA2) was less than 0.6, and therefore curing at room temperature was slow.
In Comparative Example 2, the value of (HB1+HB2+HB3)/(ViA1+ViA2) was more than 2.2, and therefore air bubbles in the cured product were confirmed, and the occurrence of peeling and a crack in the resin was observed in all the test specimens after the cold heat cycle test, and thus the reliability under high-temperature and high-humidity conditions was poor.
In Comparative Example 3, (B1) was not contained, and therefore a cured product having poor stress relaxation property and a small elongation was obtained.
In Comparative Example 4, (B2) was not contained, and therefore curing at room temperature was slow.
In Comparative Example 5, both (A2) and (B3) were not contained, and therefore a cured product having poor stress relaxation property and a small elongation was obtained.
In Comparative Example 6, the weight of (A2), relative to 100 parts by weight of the total of (A1) and (A2), was more than 60 parts by weight, and therefore curing at room temperature was slow.
In Comparative Example 7, instead of (B2), a linear polyorganohydrogensiloxane having a hydrogen atom bonded to the silicon atom in the intermediate unit was used, and therefore curing at room temperature was slow. In addition, in Comparative Example 7, air bubbles in the cured product were confirmed.
A comparison was made between Examples 10 to 15 and Example 16. In the case where the value of (HB1+HB2+HB3)/(ViA1+ViA2) (i.e., (HB1+HB2+HB3)/ViA1) is 0.6 to 1.4, the stress relaxation property was further improved, and the occurrence of peeling and a crack in the resin was not found at all after the cold heat cycle test, and thus the reliability properties after the cold heat cycle test were further improved. In Example 7, in four test specimens after the cold heat cycle test, the occurrence of peeling and a crack in the resin was not found. In Example 16, in one test specimen after the cold heat cycle test, slight peeling occurred at the corner of the test specimen, but a number of air bubbles or cracks were not observed in the test specimen. In contrast, in the Comparative Examples, a number of air bubbles and cracks were observed in all the test specimens.
A comparison was made between Examples 10 to 13 and Examples 14 to 16. In the case where the value of (HB1+HB2+HB3)/(ViA1+ViA2) (i.e., (HB1+HB2+HB3)/ViA1) was 0.6 to 0.99, a lowering of the flexibility of the cured product after the heating treatment was small, and, even after the heating treatment, the cured product had excellent stress relaxation property.
In Comparative Example 8, the value of (HB1+HB2+HB3)/(ViA1+ViA2) was less than 0.6, and therefore curing at room temperature was slow.
In Comparative Example 9, the value of (HB1+HB2+HB3)/(ViA1+ViA2) was more than 2.2, and therefore air bubbles were confirmed in the cured product after the treatment under high-temperature and high-humidity conditions, and the occurrence of peeling and a crack in the resin was observed in all the test specimens after the cold heat cycle test, and thus the reliability under high-temperature and high-humidity conditions was poor.
In Comparative Example 10, both (A2) and (B3) were not contained, and therefore the stress relaxation property was poor, and further the occurrence of peeling and a crack in the resin was observed in all the test specimens after the cold heat cycle test, and thus the reliability under high-temperature and high-humidity conditions was poor.
In Comparative Example 11, instead of (B2), a linear polyorganohydrogensiloxane having a hydrogen atom bonded to the silicon atom in the intermediate unit was used, and therefore curing at room temperature was slow. In addition, in Comparative Example 11, the stress relaxation property was poor, and bubbles were confirmed in the cured product after the treatment under high-temperature and high-humidity conditions, and the occurrence of peeling and a crack in the resin was confirmed in the two test specimens after the cold heat cycle test, and thus the reliability under high-temperature and high-humidity conditions was poor.
A comparison was made between Example 17 and Example 3, and a comparison was made between Example 18 and Example 8. With respect to the cured products having almost the same weight of (A2), relative to 100 parts by weight of the total of (A1) and (A2), and having almost the same value of (HB1+HB2+HB3)/(ViA1+ViA2), the cured products in Examples 17 and 18, in which (B3) were contained, had a further reduced penetration change ratio and excellent stress relaxation property even after the heating treatment.
The curable polyorganosiloxane composition is useful in adhering a base portion having an image display part for an image display device such as a cathode ray tube, liquid crystal, plasma or organic EL image display device, to a light-transmitting protective portion.
Okawa, Koji, Sunaga, Takeshi, Morita, Yasuhito
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4511620, | Jun 29 1984 | Dow Corning Corporation; DOW CORNING CORPORATION, A CORP OF MI | Method for prevention of bubble formation in polyorganosiloxane gels |
4709001, | Jan 02 1987 | Dow Corning Corporation | In situ low temperature siloxane gel |
4870149, | Jul 29 1987 | Shin-Etsu Chemical Co., Ltd. | Silicone composition for rendering surfaces non-adherent |
4983701, | Feb 26 1988 | Shin-Etsu Chemical Co., Ltd | Silicone composition for rendering surfaces non-adherent |
4988779, | Apr 17 1989 | GENERAL ELECTRIC COMPANY, A NY CORP | Addition cured silicone pressure sensitive adhesive |
4990560, | Sep 07 1988 | Shin-Etsu Chemical Co., Ltd. | Curable organopolysiloxane composition |
5204437, | Aug 01 1990 | Shin-Etsu Chemical Co., Ltd. | Organopolysiloxane composition and its gel cured product |
5216104, | Jul 21 1989 | Shin-Etsu Chemical Co., Ltd. | Curable silicone rubber compositions and products of curing thereof |
5279890, | Dec 07 1989 | Shin-Etsu Chemical Co., Ltd. | Silicone composite product and process for preparing the same |
5281656, | Dec 30 1992 | Dow Corning Corporation | Composition to increase the release force of silicone paper release coatings |
5571853, | Feb 09 1993 | Shin-Etsu Chemical Co., Ltd. | Gel-forming silicone composition |
5679734, | Apr 14 1995 | Bluestar Silicones France | Silicone composition which can be crosslinked into an adhesive gel |
5908897, | Jun 21 1995 | Dow Corning Toray Silicone Co., Ltd. | Silicone rubber composition |
5929162, | Dec 12 1997 | General Electric Company | Elastomer dispersion having a unique particle size distribution |
6355724, | Dec 06 2000 | CLARIANT LIFE SCIENCE MOLECULES FLORIDA , INC | Cosmetic compositions containing silicone gel |
8187490, | Jan 26 2006 | Momentive Performance Materials Japan LLC | Heat dissipating material and semiconductor device using same |
8263723, | Mar 31 2008 | DOW TORAY CO , LTD | Organopolysiloxane, method of manufacturing thereof, curable silicone composition, and cured product thereof |
20040176528, | |||
20050250903, | |||
20050272893, | |||
20090123764, | |||
20090258216, | |||
20110269918, | |||
20120322942, | |||
20130071673, | |||
20150337188, | |||
20150337189, | |||
20160108240, | |||
EP769528, | |||
EP2865719, | |||
JP63256773, | |||
JP9169908, | |||
WO2014104080, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jun 15 2017 | Momentive Performance Materials Japan LLC | (assignment on the face of the patent) | / | |||
Dec 13 2018 | MORITA, YASUHITO | Momentive Performance Materials Japan LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 047784 | /0726 | |
Dec 13 2018 | OKAWA, KOJI | Momentive Performance Materials Japan LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 047784 | /0726 | |
Dec 13 2018 | SUNAGA, TAKESHI | Momentive Performance Materials Japan LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 047784 | /0726 |
Date | Maintenance Fee Events |
Dec 14 2018 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Jul 02 2024 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Date | Maintenance Schedule |
Jan 19 2024 | 4 years fee payment window open |
Jul 19 2024 | 6 months grace period start (w surcharge) |
Jan 19 2025 | patent expiry (for year 4) |
Jan 19 2027 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jan 19 2028 | 8 years fee payment window open |
Jul 19 2028 | 6 months grace period start (w surcharge) |
Jan 19 2029 | patent expiry (for year 8) |
Jan 19 2031 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jan 19 2032 | 12 years fee payment window open |
Jul 19 2032 | 6 months grace period start (w surcharge) |
Jan 19 2033 | patent expiry (for year 12) |
Jan 19 2035 | 2 years to revive unintentionally abandoned end. (for year 12) |